<DOC>
	<DOC>NCT01734707</DOC>
	<brief_summary>This study was designed to estimate the effect of two-year treatment with time-released garlic-based drug Allicor on the progression of carotid atherosclerosis in double-blinded placebo-controlled randomized clinical trial.</brief_summary>
	<brief_title>Atherosclerosis Monitoring and Atherogenicity Reduction Study</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>Men aged 40 to 74 years Subclinical carotid atherosclerosis detected by Bmode ultrasound (increased intimamedia thickness 11002000 mcm) Arterial normotension or mild arterial hypertension (systolic blood pressure &lt;160 mm Hg, diastolic blood pressure &lt;90 mm Hg) Absence of chronic diseases demanding permanent drug administration (more than 2 month per year) Personal history or diagnostic of following diseases: 1. Transient ischemic attacks 2. Presence of chronic diseases demanding permanent drug administration (more than 2 month per year) 3. Condition of patients moderate to severe Indications for surgical treatment of atherosclerotic lesions localized in the extracranial brachiocephalic system. Individual intolerance of Allicor or appearance of side effects</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>January 2005</verification_date>
	<keyword>atherosclerosis</keyword>
	<keyword>regression</keyword>
	<keyword>Allicor</keyword>
	<keyword>garlic</keyword>
	<keyword>intima-media thickness</keyword>
</DOC>